Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $7,950 - $9,487
-164 Reduced 4.02%
3,916 $200,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $13.8 Million - $15.4 Million
-238,118 Reduced 98.32%
4,080 $236,000
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $46,253 - $51,357
726 Added 0.3%
242,198 $15.5 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $134,771 - $152,861
-2,051 Reduced 0.84%
241,472 $16.7 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $241,871 - $286,409
3,532 Added 1.47%
243,523 $17.5 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $180 - $106,653
1,388 Added 0.58%
239,991 $17.1 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $3.25 Million - $3.57 Million
44,686 Added 23.04%
238,603 $18.4 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $49,306 - $59,123
802 Added 0.42%
193,917 $14.2 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $8,688 - $10,128
162 Added 0.08%
193,115 $12 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $186,799 - $218,811
3,157 Added 1.66%
192,953 $11.4 Million
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $79,059 - $86,095
1,277 Added 0.68%
189,796 $12.7 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $273,616 - $307,738
4,611 Added 2.51%
188,519 $11.9 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $378,832 - $429,286
6,561 Added 3.7%
183,908 $11.4 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $630,179 - $698,321
10,973 Added 6.6%
177,347 $10.7 Million
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $226,022 - $264,243
-4,123 Reduced 2.42%
166,374 $9.78 Million
Q1 2020

May 18, 2020

BUY
$46.4 - $67.43 $7.91 Million - $11.5 Million
170,497 New
170,497 $9.5 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $176,608 - $229,019
-3,622 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
3,622
3,622 $202,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mc Gowan Group Asset Management, Inc. Portfolio

Follow Mc Gowan Group Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Gowan Group Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Gowan Group Asset Management, Inc. with notifications on news.